Dr. Sara Brenner, the FDA’s Principal Deputy Commissioner, has paused the approval process for Novavax’s COVID-19 vaccine, requesting additional data. This intervention coincides with the dismissal of top vaccine reviewer Dr. Peter Marks and comes just before the FDA’s deadline to license the vaccine for those aged 12 and...
Brand volutpat non nisl idele tincidunt praesent at eros vitae the pulvinar ornare uncion eleifen the interdum velit, ac accumsan duinan fermentum eman miss imperdiet urna sed efficitur euismod. Sound bullam corper purus arcu vel pretium. Vocal volutpat non nisl idele tincidunt praesent at eros vitae the pulvinar in...